Logiscreen

Bio-Rad Laboratories Inc - Class A

$369.32
Market Cap 9.88B
ROE 3.2%
Gross Margin 53.1%
Debt/Equity 0.2
Current Ratio 3.1
Revenue QoQ -0.1%
EPS QoQ 0.2%
F-Score 5

About

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees, and $2.6 billion in revenues in 2024. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Fair Value

Trading at a discount to sector peers

P/E
47.35
vs median 37.08
P/B
1.17
vs median 2.65
ROE
0.02
vs median 0.09

Decent quality with acceptable fundamentals

Mid-cap company with growth potential

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics